CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

Article Properties
  • Language
    English
  • Publication Date
    1998/04/01
  • Indian UGC (Journal)
  • Refrences
    117
  • Citations
    1,124
  • Iqbal S. Grewal Howard Hughes Medical Institute, and Section of Immunobiology, Yale University School of Medicine, New Haven, Connecticut 06520;
  • Richard A. Flavell Howard Hughes Medical Institute, and Section of Immunobiology, Yale University School of Medicine, New Haven, Connecticut 06520;
Abstract
Cite
Grewal, Iqbal S., and Richard A. Flavell. “CD40 AND CD154 IN CELL-MEDIATED IMMUNITY”. Annual Review of Immunology, vol. 16, no. 1, 1998, pp. 111-35, https://doi.org/10.1146/annurev.immunol.16.1.111.
Grewal, I. S., & Flavell, R. A. (1998). CD40 AND CD154 IN CELL-MEDIATED IMMUNITY. Annual Review of Immunology, 16(1), 111-135. https://doi.org/10.1146/annurev.immunol.16.1.111
Grewal IS, Flavell RA. CD40 AND CD154 IN CELL-MEDIATED IMMUNITY. Annual Review of Immunology. 1998;16(1):111-35.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Immunologic diseases
Allergy
Description

How do immune cells communicate and coordinate their attacks? This review explores the role of CD40-CD154 interactions in cell-mediated immunity, highlighting their importance beyond B-T cell communication. CD40, expressed on diverse cell types including dendritic cells and macrophages, interacts with CD154, influencing a wide range of immune responses. Studies using CD40- and CD154-knockout mice, along with antibodies targeting these molecules, have helped elucidate the role of this system in immune regulation. This paper shows that CD40-CD154 interactions influence T cell priming and effector functions, upregulate costimulatory molecules, and activate macrophages, NK cells, and endothelia. The discussion spans the involvement of this system in organ-specific autoimmune disease, graft rejection, and even atherosclerosis. The review focuses on the evolving understanding of CD40-CD154 in inflammation and cell-mediated immunity, pointing to how it influences T cell priming and T cell-mediated effector functions. The upregulating costimulatory molecules and activating macrophages, NK cells, and endothelia have also been noted. This research underscores the CD40-CD154 system is central to inflammation and cell-mediated immunity. Understanding these interactions could pave the way for new therapeutic interventions in autoimmune diseases and other immune-related disorders.

Published in the Annual Review of Immunology, this comprehensive review aligns with the journal's focus on cutting-edge research in immunology. By focusing on CD40-CD154 interactions and their multifaceted roles in immune responses, it addresses a central and rapidly evolving area of immunological research.

Refrences
Citations
Citations Analysis
The first research to cite this article was titled The TRAF Family of Signal Transducers Mediates NF-κB Activation by the TRANCE Receptor and was published in 1998. The most recent citation comes from a 2024 study titled The TRAF Family of Signal Transducers Mediates NF-κB Activation by the TRANCE Receptor . This article reached its peak citation in 2002 , with 107 citations.It has been cited in 403 different journals, 14% of which are open access. Among related journals, the The Journal of Immunology cited this research the most, with 157 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year